SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001521536-13-000425
Filing Date
2013-05-10
Accepted
2013-05-10 14:00:11
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 q1101084_10q-biozone.htm 10-Q 440445
2 q1101084_ex31-1.htm EX-31.1 8541
3 q1101084_ex32-1.htm EX-32.1 4758
  Complete submission text file 0001521536-13-000425.txt   3006231

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bzne-20130331.xml EX-101.INS 310047
5 XBRL SCHEMA FILE bzne-20130331.xsd EX-101.SCH 37022
6 XBRL CALCULATION FILE bzne-20130331_cal.xml EX-101.CAL 39971
7 XBRL DEFINITION FILE bzne-20130331_def.xml EX-101.DEF 112464
8 XBRL LABEL FILE bzne-20130331_lab.xml EX-101.LAB 202585
9 XBRL PRESENTATION FILE bzne-20130331_pre.xml EX-101.PRE 183845
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-608-5101
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-146182 | Film No.: 13832574
SIC: 2834 Pharmaceutical Preparations